Cardiovascular Events and Management Strategies Including Tyrosine Kinase Inhibitor Switching, Dose Reduction, and Discontinuation in Chronic Myeloid Leukemia: A Single-Center Retrospective Study.

Saved in:
Bibliographic Details
Title: Cardiovascular Events and Management Strategies Including Tyrosine Kinase Inhibitor Switching, Dose Reduction, and Discontinuation in Chronic Myeloid Leukemia: A Single-Center Retrospective Study.
Authors: Sato N; Pharmaceutical, National Cancer Center Hospital East, Kashiwa, JPN., Yoshimaru R; Hematology and Oncology, National Cancer Center Hospital East, Kashiwa, JPN., Guo YM; Hematology and Oncology, National Cancer Center Hospital East, Kashiwa, JPN., Nakamura H; Hematology and Oncology, National Cancer Center Hospital East, Kashiwa, JPN., Chi S; Hematology and Oncology, National Cancer Center Hospital East, Kashiwa, JPN., Matsuda K; Hematology and Oncology, National Cancer Center Hospital East, Kashiwa, JPN., Minami Y; Hematology and Oncology, National Cancer Center Hospital East, Kashiwa, JPN., Yuda J; Hematology and Oncology, National Cancer Center Hospital East, Kashiwa, JPN.
Source: Cureus [Cureus] 2026 Mar 21; Vol. 18 (3), pp. e105578. Date of Electronic Publication: 2026 Mar 21 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2168-8184
DOI:10.7759/cureus.105578